LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 64 filers reported holding LEAP THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,316 | -93.0% | 27,400 | -90.7% | 0.00% | – |
| Q4 2022 | $132,975 | -63.5% | 295,500 | -28.6% | 0.00% | -100.0% |
| Q3 2022 | $364,000 | -58.1% | 414,100 | -45.2% | 0.00% | -50.0% |
| Q2 2022 | $869,000 | -53.5% | 755,600 | -29.2% | 0.00% | -60.0% |
| Q1 2022 | $1,869,000 | -62.2% | 1,067,800 | -30.1% | 0.01% | -58.3% |
| Q4 2021 | $4,946,000 | +214.0% | 1,526,600 | +288.6% | 0.01% | +200.0% |
| Q3 2021 | $1,575,000 | +192.2% | 392,800 | +19.4% | 0.00% | +300.0% |
| Q2 2021 | $539,000 | -55.9% | 328,850 | -48.9% | 0.00% | -66.7% |
| Q1 2021 | $1,222,000 | -3.6% | 643,400 | +14.2% | 0.00% | 0.0% |
| Q4 2020 | $1,268,000 | +13.3% | 563,400 | -0.3% | 0.00% | 0.0% |
| Q3 2020 | $1,119,000 | +1863.2% | 565,100 | +1970.0% | 0.00% | – |
| Q2 2020 | $57,000 | – | 27,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 16,952,992 | $27,802,000 | 0.18% |
| Opaleye Management Inc. | 540,000 | $886,000 | 0.15% |
| ACT CAPITAL MANAGEMENT, LLC | 134,000 | $220,000 | 0.11% |
| Artal Group S.A. | 3,000,000 | $4,920,000 | 0.10% |
| HHLR ADVISORS, LTD. | 3,575,745 | $5,864,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 910,047 | $1,492,000 | 0.04% |
| PERSONAL CFO SOLUTIONS, LLC | 78,165 | $128,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 122,401 | $201,000 | 0.02% |
| Windsor Creek Advisors, LLC | 46,955 | $77,000 | 0.02% |
| Golden Green, Inc. | 14,824 | $24,000 | 0.02% |